Skip to main content
ILLUMINA, INC. logo

ILLUMINA, INC. — Investor Relations & Filings

Ticker · ILMN ISIN · US4523271090 LEI · SQ95QG8SR5Q56LSNF682 US Manufacturing
Open in API
Filings indexed 2,571 across all filing types
Latest filing 2024-10-09 Director's Dealing
Country US United States of America
Listing US ILMN

About ILLUMINA, INC.

https://www.illumina.com

Illumina, Inc. develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company is a provider of DNA sequencing and array-based technologies. Its portfolio includes next-generation sequencing (NGS) platforms, microarrays, library preparation kits, and bioinformatics software. These products and services are utilized by researchers and clinicians for applications in life science research, translational and consumer genomics, molecular diagnostics, oncology, and reproductive health. The company's solutions are designed to advance genomic discoveries and enable precision medicine by providing tools for DNA, RNA, and protein analysis.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2024-10-09 English
CURRENT REPORT
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated October 3, 2024, reporting a departure of a director/officer and appointment of an interim officer. The content focuses on management changes, specifically the departure of the General Counsel and Secretary and appointment of an interim replacement. There are no financial statements or detailed financial data presented. The primary subject is changes in senior management personnel, which fits the Board/Management Information category. The document length is about 5,174 characters, sufficient to contain substantive information about management changes. Therefore, the appropriate classification is MANG (Board/Management Information).
2024-10-03 English
PRIMARY DOCUMENT
Director's Dealing
2024-10-01 English
PRIMARY DOCUMENT
Director's Dealing
2024-09-17 English
PRIMARY DOCUMENT
Director's Dealing
2024-09-09 English
8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content describes the termination of a material definitive agreement (a credit agreement) and the issuance of new notes (debt financing) to repay that indebtedness. It includes details about the underwriting agreement, terms of the notes, and related exhibits. This is a clear update on the company's financing activities rather than a full financial report or earnings release. The document length is about 5990 characters, which is sufficient to provide substantive details rather than just an announcement of a report. Therefore, the filing best fits the category of Capital/Financing Update (CAP).
2024-09-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.